Esthesioneuroblastoma in children, adolescents and young adults

Bull Cancer. 2020 Sep;107(9):934-945. doi: 10.1016/j.bulcan.2020.06.002. Epub 2020 Sep 4.

Abstract

The esthesioneuroblastoma (ENB) is characterized as a rare malignant sinonasal tumor of neuroectodermal origin. Its starting point is the olfactory epithelium located in the upper part of the nasal cavities. Different nomenclatures have been proposed, but the most common are "esthesioneuroblastoma" and "olfactory neuroblastoma". ENBs have a bimodal distribution and mainly occur in teenagers, young adults and people aged 50-60. It is a very rare tumor in pediatrics since only around 100 cases have been reported so far. Within ENBs, we can distinguish tumors with different biological behavior ranging from localized forms with slow evolution to aggressive and metastatic forms at onset. In addition, precisely diagnosing undifferentiated tumors and distinguishing them from other etiologies of sinonasal tumors are sometime difficult. Added to its very low incidence, these characteristics make the study of ENB complicated. The standard treatment currently includes broad surgery followed by radiation therapy in localized resectable tumors. Neoadjuvant chemotherapy is indicated in large unresectable tumors and in metastatic forms. However, in certain indications, such as high-grade operable tumors, the role of perioperative chemotherapy remains to be defined. The objective of this analysis is to detail current knowledge regarding ENBs' epidemiological, biological, clinical and radiological characteristics as well as how to manage ENB in young patients.

Keywords: Children; Esthesioneuroblastoma; Leptomeningeal relapse; Olfactory neuroblastoma; Radiotherapy; Rare tumor.

Publication types

  • Review

MeSH terms

  • Adolescent
  • Child
  • Esthesioneuroblastoma, Olfactory / diagnosis*
  • Esthesioneuroblastoma, Olfactory / therapy*
  • Humans
  • Nasal Cavity*
  • Neoplasm Staging
  • Nose Neoplasms / diagnosis*
  • Nose Neoplasms / therapy*
  • Young Adult